IR-Med, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
IR-Med, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2020 to Q3 2024.
  • IR-Med, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $51K, a 38.6% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $51K -$32K -38.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $36K -$63K -63.6% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $55K -$1K -1.79% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $81K +$26K +47.3% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $83K $0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $99K -$70K -41.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $56K -$91K -61.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $55K -$12K -17.9% Dec 31, 2022 10-K/A 2024-04-08
Q3 2022 $83K -$26K -23.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $169K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $147K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $67K -$151K -69.3% Dec 31, 2021 10-K/A 2023-05-11
Q3 2021 $109K Sep 30, 2021 10-Q 2021-11-15
Q4 2020 $218K Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.